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Background : Chronotropic incompetence (CI) is defined as the failure of the heart to increase its heart rate along 
with activity and is an independent predictor of cardiovascular morbidity and mortality. The gold standard for CI 
is based on a treadmill test. However, up to now, there is no guideline to recommend whether CI could be 
concluded according to holter monitoring data.
Objective : This study aimed to determine CI  based on Holter monitoring, specifically using time-domain analysis 
of heart rate variability (HRV).
Methods : This study used descriptive-analytic research with cross-sectional sampling. The population was 
patients that underwent treadmill and holter monitoring. The treadmill test was used as a gold standard of CI, 
and compare to holter monitoring using heart rate variability as a parameter. Data analysis used a comparative 
study (Independent T, Mann-Whitney, Chi-Square) and multivariate analysis logistic regression with a 
significance of p < 0,05.
Results: The subjects of the study were 111 patients with male-dominant (59 men). Standard Deviation N-N 
interval (SDNN) and Standard Deviation of Average N-N Interval (SDANN) were found lower in the CI group 
compared to the normal one. Mean SDNN was 113,57 + 51,08 msec in CI group and 117,4 + 39,48 msec in 
normal group with p  = 0.282. Mean SDANN was 94,77 (73,42-118,85) in CI and 104,16 (74,9–139) with p = 
0.422. While the Proportion of RR interval with the difference > 50 ms (RR50) and Average of All N-N Intervals 
(AVNN) found to be higher in CI group, but not statistically significant (p = 0.681; p = 0.061 respectively). Other 
parameter extracted from holter result, delta HR showed significant correlation with CI (50.5 (43,25-61,5) vs. 56 
(50-72) with p = 0.014). 
Conclusion: Time-domain HRV didn’t had a significant correlation with CI. However, delta HR from holter 
monitor could be used as a predictor of CI.
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 Chronotropic Incompetence (CI) is often stated as the inabili-
ty of the heart rate to increase in order to accommodate increasing 
cardiac demand.1 More specifically, CI described as the inability to 
achieve 85% of maximum predicted heart rate adjusted to age, accord-
ing to astrand formula.2 Physiologically, the heart rate will increase 
when the body system told it to do so.3 A clear correlation between CI 
and increased mortality had been studied and established for decades.1 
Not only in patients with cardiovascular morbidity but also in those 
without any cardiovascular abnormality. Inability to reach 85%
of age-adjusted - predicted maximum heart rate is a predictor of 
mortality and future cardiovascular events, even after adjusting age 
and other cardiovascular risk factors (HR 1.75 %; CI 95%).4 
 The ability to reach the age-predicted maximal heart rate 
(APMHR) using a treadmill test is the gold standard diagnostic tool for 
CI. But it was traditionally formulated in healthy people.  However, 
there was no standardized measurement in cardiac disease. In heart 
failure patients, the standard diagnostic formula is proven not accurate. 
Therefore, the modified formula has been proven superiorly accurate in 
heart failure patients who tacking beta-blocker although there was still 
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some limitation.5 Currently, many diagnostic approaches had been 
already proposed to make the diagnosis in certain cardiovascular 
conditions. But none of them showed a promising result.6 
 Holter monitoring had been widely used for diagnosing 
arrhythmia in clinical practice. Continuous monitoring of the patient 
can reflect the dynamic condition of the heart rate. Holter monitoring 
for diagnosing CI had been studied by lie et all in 2016. It showed that 
APMHR derived from a patient’s daily activity could be used to 
diagnose CI.7 HRV is widely used to measure autonomic function. HRV 
is one parameter that could be extracted from holter result. In our 
clinical practice, we used to make non – objective or eyeballing evalua-
tion of patient heart rate fluctuation during 24 hours to determine the 
chronotropic competency. In this study, we tried to analyze holter 
monitor results and made a quantitative measurement of chronotropic 
competence using holter monitor parameters, specifically HRV parame-
ter.
 
2. Methods
2.1. Study Design
 This was a single-center observational analytic study, with a 
cross-sectional design. The study took place in Saiful Anwar General 
Hospital, Cardiovascular Integrative Unit (Instalasi Pelayanan Jantung 
Terpadu / IPJT). The study was approved by Saiful Anwar General 
Hospital and Faculty of Medicine Universitas Brawijaya’s ethical 
committee. Written informed consent was derived from all of the 
participants.  
2.3. Study Participants
 This study used purposive sampling for sample recruitment. 
We involved the patients that came to our cardiovascular rehabilitation 
unit who undergone a treadmill test procedure for various indications. 
They are asked for a willingness to did an additional 24 hours Holter 
examination. We exclude the patient with cardiac pacemaker and 
patient who had been previously diagnosed with the following 
condition:  atrio-ventricular block; frequent premature ventricular 
contraction (PVC) and patient with atrial fibrillation (AF).
2.4. Data Collection and Measurements
 A total of 117 patients was performing both treadmill test 
and Holter monitoring, but due to not meet the inclusion criteria, only 
111 patients were complete by the end of the study. 
 All the patients underwent a treadmill test using whether 
bruce or modified bruce criteria. Chronotropic incompetence was 
defined as an inability to achieve 85 % age-predicted maximum heart 
rate (APMHR) or inability to achieve 0.6 of a chronotropic index in 
patients who take beta-blockers as a part of their medication. Chrono-
tropic index (maximum HR during activity – resting HR) divided by 
(APMHR – resting HR) is a standardized measurement of increasing HR 
during exercise.8
 Holter monitor was performed for 24 hours using 12 leads 
BTL cardio-point  H 300. Standard holter measurements were record-
ed, such as maximum HR, minimum HR, delta HR, and any arrhythmia 
that being recorded. Additional time-domain HRV were automatically 
extracted from the data by the factory software. They are SDNN 
(Standard Deviation N-N interval), SDANN (Standard Deviation of 
Average N-N Interval), RMSDD (Root Mean Square of the Successive 
Differences), and pNN50 (Number of Successive Differences between 
N-N interval that greater than 50 ms).
2.5. Statistical Analysis
 Data were analyzed using SPSS for windows version 16. The 
comparison of CI and HRV parameters performed using paired student 
T-test if the data showed normal distribution or using Mann Whitney 
test if the data showed abnormal distribution. 
3. Results
3.1. Baseline Characteristics
 From July 2017 until January 2018, there were approximate-
ly 900 treadmill procedures was done in the Cardiac Rehabilitation 
Centre of  IPJT Saiful Anwar General Hospital. 117 patients willing to 
perform an additional 24 hours holter monitor procedure and joining 
the study. Six patients were excluded because of arrhythmia found in 
the holter result. Most of them were atrial fibrillation (5 patients).  CI 
was found in 52 patients (46.9 %). Of those in CI group 50 % (26 
patients) were male. While in normal group 55.93% (33 patients) were 
male. Diabetes mellitus were found more frequently in CI group  (21.15 
% vs 6.78 %, p = 0.038). Coronary artery disease, heart failure, smoker 
and beta-blocker were higher in CI group, although not statistically 
significant (p = 0.49; p = 0,057; p = 0.45 and p = 0,13 respectively).
3.2. Time domain HRV
 From HRV parameters extracted automatically from holter 
result. None of all the parameters were significantly correlated with CI. 
SDNN and SDANN were found lower in CI group compared to the 
normal group. Mean SDNN was 113,57 + 51,08 msec in CI group and 
117,4 + 39,48 msec in normal group with p  = 0.282). Mean SDANN 
was 94,77 (73,42-118,85) in CI and 104,16 (74,9–139) with p = 
0.422. While the RR50 and AVNN found to be higher in CI group, but 
not statistically significant (p = 0.681; p = 0.061 respectively).
 The only holter parameter that found to be promising was 
delta HR. The difference between the maximum and minimum HR in CI 
group was 50.5 (43,25-61,5) versus 56 (50-72) with p = 0.014.
3.3. Multivariate Analysis
 At the beginning of the study, we planned to make a model 
to quantitatively calculate the possibility of CI from time-domain HRV 
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Figure 1. Study flowchart
parameters, using logistic regression. The bivariate analysis p-value cut 
off was < 0.25. All parameters that had p-value < 0.25 will be eligible 
to join the next step analysis (logistic regression). Since there were only 
two holter parameters that had p-value < 0.25 (AVNN p = 0.061 and 
Delta HR p = 0.014), we decided not to continue to multivariate 
analysis.
4. Discussion
 In this study, we found that only Delta HR is significantly 
correlated with CI (p 0.014). While other HRV parameters such as 
SDNN and  SDANN were lower in CI group but not statistically signifi-
cant. SDNN and SDANN reflect the sympathetic and parasympathetic 
activity. In patients with CI, HR failed to increase because of sympathet-
ic activity was blunted. According to a previous study by Kawasaki et 
all, inability to reach APMHR in exercise (CI) is correlated with the 
ratio LF (Low Frequency) and HF (High Frequency), but not correlated 
with HF parameters.20 Both HF and LF/HF ratios are the frequency 
domain HRV parameter. LF/HF ratio depicting sympathetic and 
parasympathetic, while HF is an index of parasympathetic tone.21 
AVNN and Pnn50 found to be higher in CI group compared to non-CI, 
although not reached statistically significant. Unlike SDNN and 
SDANN, AVNN and pnn50 are more specific for a higher parasympa-
thetic tone.
 Delta HR, which is a simple measurement extracted from 
holter results, also found to be a significant finding to predict CI. 
Patients with lower HR fluctuation found to be significantly correlated 
with the incidence of CI. Compared to eyeballing evaluation of HR 
fluctuation during 24 hours monitoring, delta HR offers more objective 
measurement.  It opens the possibility for diagnosing CI using a 
currently popular and more simple wearable device, such as a 
smartwatch or smart band.
 In this study, CI was found in 52 patients (46.8 %). Accord-
ing to ACC/AHA CI prevalence was ranged from 9 % to 89 %.1 CI was 
found to be significantly higher in patients with diabetes mellitus type 
2 (DMT2), heart failure, smoking, and bisoprolol therapy. Patients with 
DMT2 more likely to have CI, even after adjusting age, sex, and 
symptoms of CAD according to study among 12.291 patients.9 Diabetic 
autonomic neuropathy that common in DMT2 patients has been 
believed to be responsible for the development of CI in DMT2 patients. 
Hyperglycaemia will cause oxidative stress and inflammation through 
activation of several metabolic pathways, such as Protein kinase C 
(PKC), hexosamine, and increase of Advance glycation end products 
(AGE).10 It will end in systemic neuropathy, including autonomic 
neuropathy.11
 CI is a predictor of the increment of all-cause mortality in 
patients with DMT2. Patients with CI and DMT2 developed a higher 
risk (hazard ratio 2.3; with 95 % CI 1.8 -3.1) compare to those with DM 
only or CI only (hazard ratio 1.7).9 
A. Rizal, et al. Heart Sci J 2020; 1(2): 19-23
21
Table 1. Bivariate Analysis of Categoric Variables
Note, data were presented in mean ± SD or n(%)
Note, data were presented in mean ± SD or n(%); SDNN, Standard Deviation N-N interval; SDANN, Standard Deviation of Average N-N Interval; RR50, Proportion 
of RR interval with the difference >50ms; AVNN, Average of All N-N Intervals ; HR, heart rate.
Variables CI Group (n=52) Normal Group (n=59) p 
Male 
Diabetes Mellitus 
Heart Failure  
Smoker  
Using beta-blocker  
Coronary Artery Disease  
26 (50%)
11 (21,15%)
19 (36,54%)
23 (44,23%)
30 (57,69%)
23 (44.23%)
33 (55,93%)
4 (6,78%)
12 (20,34%)
22 (37,29%)
17 (28,81%)
31 (52.5%)
0.038
0.057
0.45
0.13
0.49
Table 2. Bivariate Analysis of Numeric Variables
Variables CI Group (n=52) Normal Group (n=59) p 
 
 
 
 
  
58,9 + 11, 46
113,57 + 51,08
94,77 (73,42-118,85)
5,51 (2,56-13,46)
871,23 + 127,70
50,5 (43,25-61,5)
Age
SDNN (msec)
SDANN (msec)
RR50 (msec)
AVNN (msec)
Delta HR (x/menit)
55,7 + 11.2
117, 4 + 39,48
104,16 (74,9–139)
4,95 (1,87-16,24)
826,32 + 122,30
56 (50-72)
0,138
0,282
0,422
0,681
0,061
0,014
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Prevalence of CI also higher in heart failure patients according to our 
study. This result also matched with another previous study. The 
prevalence was ranged between 25 -70 % in various studies.12 Patients 
with heart failure are at a higher risk of developing CI, despite any 
concomitant beta-blocking agent therapy or not.13 The change in 
autonomic regulation, less contractility reserve, impaired physical 
activity, and beta-blocking agents contribute to the development of CI 
in HF patients.14
 Data regarding the outcome of heart failure’s patient with CI 
is not consistent. According to Yahya’s study in 2010, CI was not a 
significant predictor of the worst outcome.15 While another study 
indicated that the inability to achieve APMHR was an independent 
predictor of mortality in heart failure.12,13,16
 Diagnosing CI in patients who take beta-blocker was a little 
bit different from those who don’t. CI is common in patients with 
beta-blocker therapy.17  The result from a cohort study in 3.736 patients 
who take beta-blockers as routine medication, the presence of CI was 
an independent predictor of death the worst outcome.18 That’s result 
came after adjusting age, gender, concomitant risk factor, and baseline 
heart rate. Discontinuation of the therapy didn’t have a significant 
impact on reversing the CI in heart failure.19 In contrast, the weight loss 
program and exercise cardiac rehabilitation would improve CI in CAD 
patients who take beta-blockers.17
Study Limitation
 We only used one out of three HRV measurements in this 
study. According to the 1996 Task Force of European Society of 
Cardiology (ESC) and the North American Society of Pacing and 
Electrophysiology (NAPSE), HRV can be measured using three 
methods, time-domain, frequency-domain, and geometric method(22). 
Only time-domain HRV was involved in the measurement. Further 
study using a combination of time-domain, frequency-domain, and 
geometric analysis hopefully will have more power in predicting CI.
5. Conclusion
 Time-domain HRV can’t be used to predict CI according to 
the final result. However, Delta HR which is a simple measurement that 
depicting heart rate fluctuation during the day had a strong relation to 
CI. 
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